BusinessEarth Science Tech, Inc. President Commits to Donating 50,000 of his Personal Shares to Become the First Contributor to Earth Science FoundationBy Nasdaq OMXJan 18, 2018, 1:01 PM UTC
BusinessZynerba Pharmaceuticals Provides 2018 Clinical and Corporate UpdateBy Nasdaq OMXJan 3, 2018, 9:30 PM UTC
BusinessDr. Paul Carney Joins Biotica Pharmaceuticals as Neurologist Consultant and Scientific AdvisorBy Nasdaq OMXJan 3, 2018, 1:00 PM UTC
BusinessZynerba Pharmaceuticals Announces New ZYN002 Data from STAR 1 and STAR 2 Studies in Patients with Focal Seizures at the 2017 Annual Meeting of the American Epilepsy Society (AES)By Nasdaq OMXDec 3, 2017, 5:01 PM UTC
BusinessEpilepsy Foundation Champions Need for Increased Public Knowledge, Timely Diagnosis and Proper Treatment for 3.4 Million People Living with Active Seizures in the United StatesBy Nasdaq OMXNov 6, 2017, 2:00 PM UTC
BusinessAdamas Reports Recent Achievements and Third Quarter 2017 Financial ResultsBy Nasdaq OMXNov 2, 2017, 8:02 PM UTC
BusinessAdamas to Host Investor and Analyst Meeting on September 18, 2017By Nasdaq OMXSep 13, 2017, 8:53 PM UTC
BusinessAdamas Announces Topline Phase 1b Data of ADS-4101 (lacosamide) for the Treatment of Partial Onset Seizures in EpilepsyBy Nasdaq OMXSep 7, 2017, 12:30 PM UTC
